Crown MycoResin Biotech, Inc. (CMBI) is a biotechnology-focused agribusiness company dedicated to advancing agarwood resin induction through science-based, scalable solutions. The company specializes in the development and application of biotic, abiotic, and dual induction systems, enabling consistent, high-quality resin production for global agarwood markets.
At the core of CMBI’s innovation is the BarIno™ Agarwood Inoculant System, a portfolio of precision-formulated products designed to match specific tree ages, DBH classes, and production objectives. These include microbial (fungal consortium), chemical induction, and hybrid technologies that work together in a structured, stage-based protocol—from early activation to resin intensification and harvest readiness.
CMBI operates through an integrated business model that combines product supply, contract inoculation services, and revenue-sharing partnerships with plantation owners and investors. Its Contract Inoculation Agreement (CIA) framework ensures a systematic approach to application, monitoring, harvest advisory, and market linkage, aligning performance with profitability.
Driven by a commitment to sustainability, farmer inclusion, and scientific standardization, CMBI empowers growers with practical technologies and data-driven methodologies while promoting responsible agarwood production. Through continuous innovation and strategic partnerships, the company aims to establish itself as a leading force in agarwood biotechnology and resin induction systems in the Philippines and beyond.